Azathioprine Injection

Products Affected - Description

Azathioprine injection, lyophilized powder, West-Ward
100 mg vial (NDC 55390-0600-20)

Reason for the Shortage

• West-Ward Pharmaceuticals’ parent company, Hikma Pharmaceuticals, acquired azathioprine injection from Bedford in July 2014.West-Ward is not actively marketing azathioprine injection.
• There are no other manufacturers of azathioprine injection.
• The oral presentations are not affected by this shortage.

Available Products

No presentations are available.

Estimated Resupply Dates

Azathioprine injection is not currently available.

Related Shortages

• Alcohol Dehydrated Injection (Ethanol) — Resolved
• Allopurinol Injection — Resolved
• Amifostine Injection — Resolved
• Colchicine Tablets — Resolved
• Dexrazoxane Injection — Current
• Drotrecogin Alfa (Activated) Injection — No Longer Available
• Foscarnet Injection — Resolved
• Leucovorin Calcium Injection — Current
• Levocarnitine Injection — Resolved
• Mechlorethamine Hydrochloride Injection — Resolved
• Metyrosine Capsules — Resolved
• Octreotide Injection — Current
• Phenylephrine 2.5% and 10% Ophthalmic Solution — Resolved
• Sodium Fluoride Oral Drops — Resolved
• Surgical Lubricant — Resolved
• Tiopronin Tablets — Resolved
• Trace Elements Injection — Resolved
• Zinc Injection — Resolved

Updated

June 11, March 23, January 16, 2015; October 20, August 4, May 1, February 3, 2014; November 1, August 9, June 11, April 17, March 7, January 28, 2013; December 17, October 30, September 10, July 12, June 19, May 4, March 26, February 3, 2012; December 9, November 21, October 27, September 29, August 3, July 1, June 29, May 20, 2011, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.